Navigation Links
Colon Cancer Relapse Mainly Caused by Stem Cells

Scientists report that stem cells are primarily responsible for the relapse of colon cancer. Stem cells are totipotent cells that have the capacity to// grow into any tissue.

Earlier researches have shown that in spite of being treated with chemotherapy, some cancers always return . These include breast cancer, blood cancer and brain cancer.

John Dick of the University of Toronto told reporters that researchers were aware that stem cells were the cause for relapse in breast , blood and brain cancer and wanted to find out if a similar mechanism was at work with colon cancer as it is one of the leading causes of cancer death in many parts of the world.

"It's critically important because the reality is that despite the therapies that we have available today, still a great number of people who have colon cancer relapse, which means that our therapies are not completely effective," said John Dick.

The results of this study was published in the journal Nature. Dick and colleagues describe their work in which they used a stem cell marker, called CD133 in colon cancer. CD133 had earlier been tried in prostate and brain cancers.

Only a small number of colon cancer cells about one in 250 was found to be rich in CD133.

Dick and his team of researchers discovered that when human colon cancer cells high in CD133 were injected into mice, the tumors were formed at a faster rate and when cells with small amounts of CD133 were given they hardly grew.

A separate paper also published in Nature supports this study that only a very small number of colon cancer cells are responsible for tumor growth.
PRI
'"/>




Page: 1

Related medicine news :

1. Cancers of Colon & Rectum linked to Cigarette Smoking
2. Need for Colon cancer screening
3. Beer guards against Colon Cancer
4. Important substance in curry conciliate Inflamed Colon
5. Colon cancer linked with common virus
6. Colon cancer risk linked to genes causing Hemochromatosis
7. Death Risk Higher in Obese Women with Colon Cancer
8. Inflammation Linked to Colon Cancer
9. Aspirin Found To Reduce The Risk Of Colon Cancer
10. Blood Marker Found To Predict Colon Cancer
11. Estrogen Found To Protect the Colon Against Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
(Date:9/22/2017)... ... ... “Letters From Home”: a moving compilation of letters that remind readers of the ... is the creation of published author, John Allred, a passionate leader of ministry to ... who has traveled and ministered on four continents. , “It is my hope and ...
(Date:9/21/2017)... , ... September 21, 2017 , ... With ProSlideshow Portrait ... and easy to do. Users can select from up to two layers of subject ... click of a mouse all within Final Cut Pro X. , With ...
(Date:9/21/2017)... , ... September 21, 2017 , ... ... learn with Infinity Behavioral Health Services for professionals in the addiction treatment industry ... Payer Audit . , Insurance companies and state and federal governments are ...
(Date:9/21/2017)... ... September 21, 2017 , ... Bill Howe Plumbing’s mission is to create an ... to the community. For over 37 years, they have operated with their mission at ... in San Diego. They were chosen as the Best San Diego plumber in ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology: